Number of Patients (n = 63) | |
---|---|
Mean age, yr (range) | 50.37 (17, 77) |
Male: female | 40: 23 |
Months of antifungal treatment, median (range) | 6 (3, 20) |
Immunocompromised, n (%) | 16 (25.4) |
Severe diabetes mellitus | 1 (1.6) |
Malignant diseases | 7 (11.1) |
Glucocorticoid or immunosuppressant therapy | 11 (17.5) |
Symptoms, n (%) | |
Asymptomatic | 32 (50.8) |
Cough | 28 (44.4) |
Sputum | 17 (27.0) |
Fever | 11 (17.5) |
Chest pain | 7 (11.1) |
CrAg titre, median (range) | 1:40 (0, 1:1280) |
CT characteristics, n (%) | |
CT number/HU, median (range) | − 45 (− 853, 55) |
Area of lesions/cm2, median (range) | 2.79 (0.09, 59.52) |
Single lesion | 38 (60.3) |
Nodule-type | 35 (55.6) |
Mass-type | 28 (44.4) |
Halo sign | 18 (28.6) |
Air-bronchogram sign | 19 (30.2) |
Cavitation | 13 (20.6) |
Peripheral | 49 (77.8) |
Lower lobe | 35 (55.6) |